首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Preparation of the Branch Bark Ethanol Extract in Mulberry Morus albay Its Antioxidation, and Antihyperglycemic Activity In Vivo
【24h】

Preparation of the Branch Bark Ethanol Extract in Mulberry Morus albay Its Antioxidation, and Antihyperglycemic Activity In Vivo

机译:在桑椹莫胡山虎中的抗氧化和体内抗血糖活性的制备

获取原文
获取原文并翻译 | 示例
           

摘要

The biological activities of the branch bark ethanol extract (BBEE) in the mulberry Morus alba L. were investigated. The determination of active component showed that the flavonoids, phenols, and saccharides are the major components of the ethanol extract. The BBEE had a good scavenging activity of the l,l-diphenyl-2-picrylhydrazyl (DPPH) radical with around 100 mug/mL of IC50 value. In vitro assay revealed that the BBEE strongly inhibited both a-glucosidase and sucrase activities whose IC50 values were 8.0 and 0.24 mug/mL, respectively. The kinetic analysis showed that the BBEE as a kind of a-glucosidase inhibitor characterized a competitive inhibition activity. Furthermore, the carbohydrate tolerance of the normal mice was obviously enhanced at 0.5 h (P < 0.05) and 1.0 h (P < 0.05) after the BBEE intragastric administration as compared to negative control. At 0.5,1.0,1.5, and 2.0 h after the intragastric administration with starch, the postprandial hyperglycemia of the type 2 diabetic mice can be significantly decreased (P < 0.01) by supplying various concentrations of the BBEE (10-40 mg/kg body weight). Therefore, the BBEE could effectively inhibit the postprandial hyperglycemia as a novel a-glucosidase activity inhibitor for the diabetic therapy.
机译:桑椹乙醇萃取物(BBEE)的生物活性在桑椹森菊属L.进行了研究。活性组分的测定表明,黄酮类,酚和糖是乙醇提取物的主要组分。 BBEE具有L,L-二苯基-2-普里德里三酰胺(DPPH)的良好清除活性,其中约100麦克风/ mL IC 50值。体外测定表明,BBEE强烈地抑制了IC50值为8.0和0.24立式/ mL的葡糖苷酶和蔗糖酶活性。动力学分析表明,BBEE作为一种A-葡糖苷酶抑制剂,其特征在于竞争性抑制活性。此外,与阴性对照相比,在BBEE胃内给药后,正常小鼠的碳水化合物耐受性明显增强了0.5小时(P <0.05)和1.0小时(P <0.05)。在0.5,1.0,1.5和2.0小时后,用淀粉灌输后,2型糖尿病小鼠的餐后高血糖通过供应各种浓度的BBEE(10-40mg / kg体内)可以显着降低(P <0.01)重量)。因此,BBEE可以有效地抑制餐后高血糖作为用于糖尿病疗法的新型A-葡萄糖苷酶活性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号